<DOC>
	<DOCNO>NCT02554344</DOCNO>
	<brief_summary>The purpose study determine safety , feasibility , regression rate use curcumin patient Cervical Intraepithelial neoplasia ( CIN3 ) . The secondary objective study evaluate patient CIN3 presence high-risk Human papillomavirus ( HPV ) perform inflammatory panel dysplasia biopsy patient CIN3 determine factor play role persistence CIN3 .</brief_summary>
	<brief_title>Effect Curcumin Treatment Squamous Cervical Intraepithelial Neoplasias ( CINs )</brief_title>
	<detailed_description>Fourteen woman biopsy-confirmed CIN3 diagnosis enrol . The participant receive 500mg curcumin orally twice daily 12 week . Colposcopies perform participant ' baseline , 6 week , 12 week visit . Two biopsy perform baseline 12 week visit , suspicion cancer formation invasion , 6-week visit . One sample use histologic examination , sample use p65 assay . Based biopsy , cancer present , patient refer gynecologic oncology care trial terminate . At end 12 week period , CIN3 persist , Loop electrosurgical excision procedure ( LEEP ) Cold knife conisation ( CKC ) perform remove dysplastic cell consider standard care .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>A patient eligible inclusion study meet follow criterion : 1 . The patient must 21 old able give inform consent . 2 . Patient must histologically confirm squamous CIN3 . 3 . There must adequate colposcopy . 4 . Patient must abnormal cell endocervical curettage ( ECC ) . 5 . There must suspicion invasion . A patient ineligible inclusion study meet follow criterion : 1 . Women pregnant lactating . 2 . HIV+ status 3 . Adenocarcinoma situ invasive cancer cervix . 4 . Gallstones bile duct obstruction . 5 . Patients anticoagulant/antiplatelet therapy . 6 . Patients immunosuppressive therapy . 7 . Patients may receive investigational treatment participate study . 8 . Concurrent severe , uncontrolled infection intercurrent illness include , limited , ongoing active infection , psychiatric illness/social situation would limit compliance study requirement .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>CIN3</keyword>
	<keyword>Squamous CIN3</keyword>
</DOC>